Form D · Other
ACP Cure Acquisition LLC
New York, NY · CIK 0001706221
Offering snapshot reported Jun 14, 2017 · SEC filing
- Reported sold
- $135M Offering amount: $135M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 2, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2017 | Initial | $134,959,064 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-288760
Source: Form D, filed Jun 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Cafasso | Executive |
| Benjamin Silbert | Executive |
| Sriram Venkataraman | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
65 E. 55 Th Street, 18 Th Floor
New York, NY, 10022
New York, NY, 10022